Answers are grounded in this paper and cite their sources.
Portal vein thrombosis (PVT) is a frequent complication in patients with liver cirrhosis, often leading to a deterioration in patients' clinical condition.The treatment of PVT relies on anticoagulation therapy.The main key of therapy is to achieve recanalization of the portal vein and reduce thrombus progression, leading to a reduced risk of portal hypertension-related complications.Numerous anticoagulant drugs, such as VKAs, DOACs, and LMWH, have been investigated regarding their effectiveness and safety profiles.This article presents a deep analysis of the effectiveness of various treatments for PVT in cirrhotic patients.
No takes yet. Share an insight, caveat, or question.
Dworak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: